PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Cardiac MR sheds light on obscure heart muscle condition

2010-11-18
(Press-News.org) Left ventricular non-compaction (LVNC), a cardiomyopathy about which little is fully understood, is associated with heart failure (HF), stroke and ventricular arrhythmias, according to a study to be presented Nov. 17 at the 2010 American Heart Association (AHA) Scientific Sessions in Chicago. The researchers also will report that advanced imaging technologies reveal that developing these cardiac risks appear to progress over time in patients with LVNC.

LVNC is an inherited heart muscle condition in which the muscular wall of the left ventricle appears to be spongy and non-compacted, consisting of a meshwork of numerous muscle bands (trabeculations). However, its cause, development, clinical course and treatment are the focus of ongoing research. As a result, the study authors said that the cardiology community's "understanding of the natural history of LVNC continues to evolve."

"Our ability to detect and recognize this condition has grown considerably over the past decade, as our imaging technologies have advanced," says study investigator William T. Katsiyiannis, MD, director of the Genetic Arrhythmia Center and a clinical cardiac electrophysiologist at the Minneapolis Heart Institute® at Abbott Northwestern Hospital in Minneapolis. "Fifteen years ago, the main tool to examine cardiac muscle was echocardiography, which was not as sensitive as it is today. Now, with the advent of cardiac MR [magnetic resonance], we are able to see far more detail of the heart."

While the current incidence rate of LVNC is unknown, Katsiyiannis hypothesizes that the condition may be far more common than has been previously postulated, due to a lack of diagnosis.

Previous data have indicated complications for patients with LVNC include stroke from blood clots that form in the non-compacted tissue, the development of heart failure or left ventricular dysfunction and the development of potentially dangerous ventricular arrhythmias.

To assess the association of LVNC with these traditional risk factors, the researchers assessed patients by echocardiography or cardiac MR, and diagnosed 125 patients with LVNC. Only 38.2 percent were diagnosed by echocardiography.

"The incidence rates are unclear because echo has been the gold standard," says Katsiyiannis. "Echo missed the majority of patients with LVNC. Therefore, LVNC cannot be ruled out based on a normal echo."

The study's patient population had a higher than expected incidence of congestive heart failure (38.5 percent), left ventricular dysfunction with ejection fraction of less than 45 percent by cardiac MR (31.9 percent) and ventricular tachycardia (24.8 percent). In addition, the researchers at Minneapolis Heart Institute® reported that 3.1 percent of patients experienced stroke and 3.1 percent experienced sudden death.

Katsiyiannis concludes that LVNC requires "much more research before clinical decisions are based on its diagnosis."

###

Minneapolis Heart Institute®

The Minneapolis Heart Institute® is recognized internationally as one of the world's leading providers of heart and vascular care. This state-of-the-art facility combines the finest in personalized patient care with sophisticated technology in a unique, family-oriented environment. The Institute's programs, a number of which are conducted in conjunction with Abbott Northwestern Hospital, address the full range of heart and vascular health needs: prevention, diagnosis, treatment and rehabilitation.

Minneapolis Heart Institute Foundation

The Minneapolis Heart Institute Foundation is dedicated to creating a world without heart disease through groundbreaking clinical research and innovative education programs. MHIF's mission is to promote and improve cardiovascular health, quality of life and longevity for all.

END



ELSE PRESS RELEASES FROM THIS DATE:

Racial profiling to limit terror attacks is fundamentally flawed

2010-11-18
Stop using racial profiling, says Professor William Press from the University of Texas at Austin. He claims that as well as being politically and ethically questionable, racial profiling does no better in helping law enforcement officials in their task of catching terrorists than standard uniform random sampling techniques. This is the topic of a paper publishing today in Significance, the magazine of the Royal Statistical Society and the American Statistical Association. Racial profiling rests on the idea that people from particular racial or ethnic groups are more ...

Regenerative stem cell therapy offers new hope for treating cardiovascular disease

2010-11-18
Northwestern Medicine physician researchers are revolutionizing treatment of cardiovascular disease by utilizing patients' own stem cells to regenerate heart and vascular tissue. Northwestern Medicine is the lead site for a study examining stem cell transplantation as treatment for critical limb ischemia. Chief investigator Douglas Losordo, MD, director of the Program in Cardiovascular Regenerative Medicine at Northwestern Memorial Hospital and the Eileen M. Foell Professor of Heart Research of Northwestern University's Feinberg School of Medicine, will present the findings ...

Caltech physicists demonstrate a four-fold quantum memory

Caltech physicists demonstrate a four-fold quantum memory
2010-11-18
PASADENA, Calif. — Researchers at the California Institute of Technology (Caltech) have demonstrated quantum entanglement for a quantum state stored in four spatially distinct atomic memories. Their work, described in the November 18 issue of the journal Nature, also demonstrated a quantum interface between the atomic memories—which represent something akin to a computer "hard drive" for entanglement—and four beams of light, thereby enabling the four-fold entanglement to be distributed by photons across quantum networks. The research represents an important achievement ...

New drug targets vitamin D receptors in hormone resistant prostate cancers

2010-11-18
A new anti-cancer drug aimed at vitamin D receptors on cancer cells has prompted encouraging responses in the levels of PSA (prostate specific antigen) in men with prostate cancer that has become resistant to hormonal therapies. Results of the phase II(a) clinical trial will be presented at the 22nd EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Berlin today (Thursday). The trial found that when the new drug, inecalcitol, was combined with the existing, current therapy (docetaxel and prednisone) 83% of patients responded to the treatment ...

Tiny Trojan horses attack brain cancer cells

2010-11-18
Scientists in Germany have developed a way of smuggling an anti-cancer drug past the protective blood-brain barrier and into brain tumours and metastases using a nanocarrier – a tiny capsule specially designed to pass through cell membranes and deliver its anti-cancer drug to the cancer cell. The blood-brain barrier is formed by a network of closely sealed endothelial cells in the brain's capillaries, and it expresses a high level of proteins that pump foreign molecules away from the brain, while allowing others (such as glucose and insulin) that are necessary to the ...

Researchers trap antimatter atoms

Researchers trap antimatter atoms
2010-11-18
In the movie Angels and Demons, scientists have solved one of the most perplexing scientific problems: the capture and storage of antimatter. In real life, trapping atomic antimatter has never been accomplished, until now. A team made up of researchers from the University of Calgary, institutions across Canada and around the world have discovered how to trap atomic antimatter and the results of their discovery is published in the journal Nature. "This is a major discovery. It could enable experiments that result in dramatic changes to the current view of fundamental ...

PARP inhibitor, MK-4827, shows anti-tumor activity in first trial in humans

2010-11-18
A new drug that targets proteins responsible for helping cancer cells to repair damage to their DNA has shown promising anti-tumour activity in its first trial in humans. Some patients with a range of solid tumours, many of whom had been treated unsuccessfully for their cancer with other therapies, have seen their tumours shrink or stabilise for periods of between 46 days to more than a year. The research will be presented at the 22nd EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Berlin today (Thursday). Laboratory studies of the drug, MK-4827, ...

NIH experts describe influenza vaccines of the future

2010-11-18
WHAT: In a review article appearing in the New England Journal of Medicine, scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, examine research under way to address the limitations of currently available influenza vaccines and develop more efficient and reliable strategies to make vaccines to protect against seasonal as well as pandemic influenza. Although licensed seasonal flu vaccines safely and effectively protect most people who receive them from illness and death, the degree of protection varies ...

Structure of Lassa virus protein reveals viral thievery

2010-11-18
Scientists at Emory University and the University of St. Andrews have solved the structure of a key protein from Lassa virus, which is endemic to West Africa and can cause a deadly hemorrhagic fever. The structure reveals how the virus evades its host's immune system, and how it hijacks infected cells' vital machinery in a process scientists call "cap-stealing." Details of the structure could guide future efforts at antiviral drug discovery and vaccine development. The results are published in this week's issue of Nature. Lassa virus represents a family of viruses ...

Nation's top hospital organ transplant centers identified by HealthGrades

2010-11-18
GOLDEN, Colo. (November 17, 2010) – HealthGrades, the nation's leading independent ratings organization, today made available to organ transplant patients a list of those hospitals with the best track record for survival and chances of receiving a donor organ. HealthGrades annual evaluation of the nation's top-performing hospitals in organ transplantation includes clinical quality data, based on patient outcomes, for each of the 210 adult acute care hospitals that perform transplants. This information is available, free to the public, at HealthGrades.com and is intended ...

LAST 30 PRESS RELEASES:

Metformin changes blood metal levels in humans

Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation

Fractional flow reserve–guided complete vs culprit-only revascularization in non–ST-elevation myocardial infarction and multivessel disease

Participation of women in cardiovascular trials from 2017 to 2023

Semaglutide and tirzepatide in patients with heart failure with preserved ejection fraction

Changes in biology of internal fat may be the leading cause of heart failure

Transcatheter or surgical treatment of patients with aortic stenosis at low to intermediate risk

Promising new drug for people with stubborn high blood pressure

One shot of RSV vaccine effective against hospitalization in older adults for two seasons

Bivalent RSV prefusion F protein–based vaccine for preventing cardiovascular hospitalizations in older adults

Clonal hematopoiesis and risk of new-onset myocarditis and pericarditis

Risk of myocarditis or pericarditis with high-dose vs standard-dose influenza vaccine

High-dose vs standard-dose influenza vaccine and cardiovascular outcomes in older adults

Prevalence, determinants, and time trends of cardiovascular health in the WHO African region

New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers

CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients

Systolic blood pressure and microaxial flow pump–associated survival in infarct-related cardiogenic shock

Beta blockers, the standard treatment after a heart attack, may offer no benefit for heart attack patients and women can have worse outcomes

High Mountain Asia’s shrinking glaciers linked to monsoon changes

All DRII-ed up: How do plants recover after drought?

Research on stigma says to just ‘shake it off’

Scientists track lightning “pollution” in real time using NASA satellite

Millions of women rely on contraceptives, but new Rice study shows they may do more than just prevent pregnancy

Hot days make for icy weather, Philippine study finds

Roxana Mehran, MD, receives the most prestigious award given by the European Society of Cardiology

World's first clinical trial showing lubiprostone aids kidney function

Capturing language change through the genes

Public trust in elections increases with clear facts

Thawing permafrost raised carbon dioxide levels after the last ice age

New DNA test reveals plants’ hidden climate role

[Press-News.org] Cardiac MR sheds light on obscure heart muscle condition